← back to search

Richard T. Bradshaw

Ironwood Pharmaceuticals (United States) · US
Area of research
Molecular Biology · Spectroscopy
Research interest
Research interests include Protein Structure and Dynamics, Mass Spectrometry Techniques and Applications, Enzyme Structure and Function, and Spectroscopy and Quantum Chemical Studies.
h-index
12
citations
583
works
45
NIH funding
primary concept
email

Recent publications

Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
Nature Communications 2023cited by 82position: middledoi
Integrating Hydrogen Deuterium Exchange–Mass Spectrometry with Molecular Simulations Enables Quantification of the Conformational Populations of the Sugar Transporter XylE
Journal of the American Chemical Society 2023cited by 27position: middledoi
Insights into autoregulation of a membrane protein complex by its cytoplasmic domains
Biophysical Journal 2022cited by 1position: middledoi
Interplay and dynamics of the osmotic stress-sensing regulatory domains of the transporter BetP
Biophysical Journal 2022cited by 0position: middledoi
Autoregulation of a trimeric transporter involves the cytoplasmic domains of both adjacent subunits
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 0position: middledoi
Advanced Potential Energy Surfaces for Molecular Simulation
The Journal of Physical Chemistry B 2016cited by 89position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Veronika Heinz · University of Regensburg3 papers (2022–2022)Vanessa Leone · Medical College of Wisconsin3 papers (2022–2022)Lucy R. Forrest · National Institute of Neurological Disorders and Stroke3 papers (2022–2022)Caroline Koshy · National Institute of Neurological Disorders and Stroke3 papers (2022–2022)Christine Ziegler · Johannes Gutenberg University Mainz3 papers (2022–2022)Paul S. Lee · National Institute of Neurological Disorders and Stroke3 papers (2022–2022)Valeria Calvaresi · University of Copenhagen2 papers (2023–2023)Cristina Fenollar‐Ferrer · National Institute of Neurological Disorders and Stroke2 papers (2022–2022)Argyris Politis · University of Manchester2 papers (2023–2023)Chloë Roustan · The Francis Crick Institute1 papers (2023–2023)S.J. Gamblin · The Francis Crick Institute1 papers (2023–2023)Jason Swails · Io Therapeutics (United States)1 papers (2016–2016)Jay W. Ponder · Washington University in St. Louis1 papers (2016–2016)Alex Albaugh · University of Southampton1 papers (2016–2016)Yuezhi Mao · University of California, Berkeley1 papers (2016–2016)Eamonn Reading · King's College London1 papers (2023–2023)Teresa Head‐Gordon · Pitzer College1 papers (2016–2016)Peter Eastman · Stanford University1 papers (2016–2016)Lee‐Ping Wang · Massachusetts Institute of Technology1 papers (2016–2016)D.J. Benton · The Francis Crick Institute1 papers (2023–2023)